HCM III Acquisition Corp. is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Stamford, Connecticut. The company went IPO on 2025-08-01. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm may pursue an initial business combination in any business or industry. The company has no operations and has not generated any revenue.
根据最新的财务报表(Form-10K),HCM III Acquisition Corp 的总资产为 $0,净亏损为 $0
HCMA 的关键财务比率是什么?
HCM III Acquisition Corp 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
HCM III Acquisition Corp 的收入按细分市场或地理位置如何划分?
HCM III Acquisition Corp 最大收入来源是 Therapeutic Innovations,在最近的收益报告中收入为 154,904,000。就地区而言, United States 是 HCM III Acquisition Corp 的主要市场,收入为 154,904,000。